Navigation Links
Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRT's Centralized Cardiac Safety Services
Date:11/27/2007

referral fees over the term of the marketing agreement.

Covance is maintaining its full-year 2007 earnings target of $2.65 per diluted share, excluding any gain resulting from the sale of its centralized ECG business. In 2008, Covance continues to target revenue growth in the low- to mid-teens range and diluted earnings per share growth of 20%, excluding any gain resulting from any future contingent consideration received from the sale of the centralized ECG business.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with revenues over the last twelve months of approximately $1.5 billion, global operations in more than 20 countries, and approximately 8,700 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

Based in Philadelphia, Pennsylvania, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology, and medical device industries on a global basis. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigati
'/>"/>

SOURCE Covance Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Covance to Present at the UBS Global Life Sciences Conference
2. Covance Elects Dr. Gary E. Costley to Board of Directors
3. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
4. Wild American Shrimp Board Agrees To Implement New Self-Funding Measures
5. Medical Services International Agrees to Retail the VScan Hepatitis B&C Test Kits in SE Asia
6. CSC Agrees to Acquire First Consulting Group
7. Scientists Spot Brains Free Will Center
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
10. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
11. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... NJ (PRWEB) July 31, 2014 A cancer ... of people survive cancer and resume normal lives. This is ... Cancer Society, will affect one in seven American men but ... has a five-year survival rate of nearly 100% and a ... illness but most men diagnosed with the disease do not ...
(Date:7/31/2014)... its latest blog post, Best Drug Rehabilitation , which ... during a stay in rehab can make a big difference ... on nine secrets that addicts don’t want others to know. ... an addict from a mile away, and totally understand what’s ... Per Wickstrom . “However, take it from me: spotting ...
(Date:7/31/2014)... In its latest blog post, Best Drug ... family close by during a stay in rehab can make ... successful, is looking at 10 tips to help drug or ... is a lifelong process, and one that former addicts and ... compromise,” commented Best Drug Rehabilitation’s CEO Per Wickstrom . ...
(Date:7/31/2014)... 31, 2014 Thanks to its ... erythritol has long been used as a medium ... and monk fruit. However consistent, dependable sourcing of ... to meet food and beverage manufacturers’ increasing needs ... has launched GMO-free ErysweetTM Erythritol. , “Erysweet ...
(Date:7/31/2014)... Arizona (PRWEB) July 31, 2014 Nuanced ... announce the launch of the Nuanced Medical website ... created for the needs of the Medical Industry. , ... products and services for medical practices to meet continuously ... regulations being the HIPAA Act (Health Insurance Portability and ...
Breaking Medicine News(10 mins):Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 2Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 3Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 4Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 2Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 3Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2
... drugs , , WEDNESDAY, June 17 (HealthDay News) -- ... invade the nervous system of patients with a blood-borne ... the development of drugs that block these molecules and ... which primarily strikes children and adolescents, the bone marrow ...
... ... has been regularly engaging its healthcare provider customers in discussions about healthcare reform, the ... technology to address short and long-term healthcare objectives. , ... Stamford, CT (Vocus) June 18, 2009 -- ...
... Today the National Multiple Sclerosis Society - Wisconsin ... 2009 Physician Appreciation Award. The recognition commends Dr. Khatri ... and his research to treat it. , , ... honored to receive this recognition," says Dr. Khatri, medical ...
... 17 PRA International, a leading Clinical Research Organization, announces ... Information Association (DIA) meeting June 21 - 25 in San ... Executive Director of Medical Affairs will make a presentation entitled ... , In addition, Dr. Starkey and other PRA medical, ...
... , Redskins Kicker Shaun Suisham,s Foursome Takes First Place , ... 23rd Annual Maryland Golf Classic presented by Capital Carpets & ... kidney disease in the Washington DC area, a region that ... The tournament took place on June 15 at the picturesque ...
... quality improvement and affordable coverage for all Americans , ... Majority Leaders Howard Baker, Tom Daschle and Bob Dole, ... today released a bipartisan, budget-neutral framework for comprehensive health ... health coverage. The Leaders, Project on the State of ...
Cached Medicine News:Health News:Taking Aim at Relapse of Leukemia in Kids 2Health News:IVANS Hit Experts Available To Discuss the Dept. of HHS Recommendation Of “Meaningful Use” and How Potential Tighter Standards Will Impact the Provider Community 2Health News:IVANS Hit Experts Available To Discuss the Dept. of HHS Recommendation Of “Meaningful Use” and How Potential Tighter Standards Will Impact the Provider Community 3Health News:Aurora Physician Recognized for Multiple Sclerosis Care 2Health News:PRA International Experts Present at the 45th Annual DIA Meeting 2Health News:National Kidney Foundation's 23rd Annual Maryland Golf Classic Raises Funds to Fight Kidney Disease 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform 3Health News:Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform 4
(Date:7/31/2014)... De Pfizer Clinical Research Unit (PCRU) heeft ... van Japanse komaf voor medewerking aan klinisch onderzoek. De ... één van twee onderzoekseenheden van Pfizer , een ... door de ontdekking en ontwikkeling van nieuwe medicijnen. Om ... mannen en vrouwen van Japanse komaf – leeftijd 18 ...
(Date:7/30/2014)... 2014  Cepheid (Nasdaq: CPHD ) ... Premier will end on September 30, 2014.  Customers ... able to continue their relationship with Cepheid through ... and ROi, in addition to the recently announced ... "Cepheid has always recognized and supported the ...
(Date:7/30/2014)... 30, 2014 The Board of Directors ... last evening expressed support for the "Pharmacists, Patient ... of Pharmacy Practitioners (JCPP).  As a JCPP member, ... two-year period to develop a scalable, viable and ... "Pharmacists are fast becoming one of the ...
Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2
... April 5, 2011 Danaher Corporation (NYSE: ... been promoted to Senior Vice President and Amir Aghdaei ... and Group Executive of Danaher. In his ... Danaher,s Dental segment, which includes KaVo Group and Sybron ...
... 5, 2011 Practice Fusion, the fastest growing ... $23 million Series B round of financing led ... Management and Glynn Capital Management, as well as ... round brings the company,s total funding to $30 ...
Cached Medicine Technology:Danaher Announces Executive Appointments 2Founders Fund Leads $23 Million Practice Fusion Financing Round 2Founders Fund Leads $23 Million Practice Fusion Financing Round 3Founders Fund Leads $23 Million Practice Fusion Financing Round 4Founders Fund Leads $23 Million Practice Fusion Financing Round 5
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: